1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum

C46H37N4OPt- — CID 162465541

IUPAC1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum
SMILES[2H]C([2H])([2H])c1ccnc(-n2c3[c-]c(C(c4[c-]c(N5[OH+]N(C(C)C)c6ccccc65)ccc4)(c4ccccc4)c4ccccc4)ccc3c3ccccc32)c1.[Pt]
InChIInChI=1S/C46H36N4O.Pt/c1-32(2)49-42-23-12-13-24-43(42)50(51-49)38-20-14-19-36(30-38)46(34-15-6-4-7-16-34,35-17-8-5-9-18-35)37-25-26-40-39-21-10-11-22-41(39)48(44(40)31-37)45-29-33(3)27-28-47-45;/h4-29,32H,1-3H3;/q-2;/p+1/i3D3;
InChIKeyMWLLECSNBXFFHZ-FJCVKDQNSA-O
MW859.93 g/mol
LogP10.67
Rot. Bonds8

About 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum

1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum (PubChem CID 162465541) has the molecular formula C46H37N4OPt- and a molecular weight of 859.93 g/mol. Its IUPAC name is 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum.

Molecular Properties

Compound Name1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum
PubChem CID162465541
Molecular FormulaC46H37N4OPt-
Molecular Weight859.93 g/mol
Exact Mass859.28
IUPAC Name1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum
SMILES[2H]C([2H])([2H])c1ccnc(-n2c3[c-]c(C(c4[c-]c(N5[OH+]N(C(C)C)c6ccccc65)ccc4)(c4ccccc4)c4ccccc4)ccc3c3ccccc32)c1.[Pt]
InChIInChI=1S/C46H36N4O.Pt/c1-32(2)49-42-23-12-13-24-43(42)50(51-49)38-20-14-19-36(30-38)46(34-15-6-4-7-16-34,35-17-8-5-9-18-35)37-25-26-40-39-21-10-11-22-41(39)48(44(40)31-37)45-29-33(3)27-28-47-45;/h4-29,32H,1-3H3;/q-2;/p+1/i3D3;
InChIKeyMWLLECSNBXFFHZ-FJCVKDQNSA-O
XLogP10.67
TPSA37.10 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500859.93
LogP ≤ 510.67
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'charged_oxygen_or_sulfur_atoms', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum?
The IUPAC name of 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum (CID 162465541) is 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum.
What is the SMILES notation for 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum?
The canonical SMILES for 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum is [2H]C([2H])([2H])c1ccnc(-n2c3[c-]c(C(c4[c-]c(N5[OH+]N(C(C)C)c6ccccc65)ccc4)(c4ccccc4)c4ccccc4)ccc3c3ccccc32)c1.[Pt].
What is the InChIKey of 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum?
The InChIKey is MWLLECSNBXFFHZ-FJCVKDQNSA-O. The full InChI is InChI=1S/C46H36N4O.Pt/c1-32(2)49-42-23-12-13-24-43(42)50(51-49)38-20-14-19-36(30-38)46(34-15-6-4-7-16-34,35-17-8-5-9-18-35)37-25-26-40-39-21-10-11-22-41(39)48(44(40)31-37)45-29-33(3)27-28-47-45;/h4-29,32H,1-3H3;/q-2;/p+1/i3D3;.
What are the key properties of 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum?
1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum has a molecular weight of 859.93 g/mol, XLogP of 10.67, 8 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-[diphenyl-[9-[4-(trideuteriomethyl)-2-pyridinyl]-1H-carbazol-1-id-2-yl]methyl]benzene-2-id-1-yl]-3-propan-2-yl-2,1,3-benzoxadiazol-2-ium;platinum is sourced from PubChem (CID 162465541), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).